Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: Preliminary results from a phase II trial

1. Pelegrí, A.
2. Calvo, L.
3. Mayordomo, J.I.
4. Florián, J.
5. Vázquez, S.
6. Arcusa, A.
7. Martín-Richard, M.
8. Bayo, J.L.
9. Virizuela, J.
10. Carrasco, E.
11. Antón, A.